Introduction
G-protein coupled receptors (GPCRs) are major players in cell-cell communication (Bockaert and Pin, 1999) . These receptors are encoded by more than one percent of the mammalian genes and are the target of about 50% of the drugs on the market. Although our knowledge of their activation mechanism, as well as of the various processes involved in their regulation, has expanded extensively within the last ten years, it is still unclear how these receptors stimulate the GDP-GTP exchange in heterotrimeric G-proteins. For many years it was assumed that GPCRs are monomers, one receptor molecule being activated by a single ligand and activating one heterotrimeric G-protein.
However, recent studies revealed that these receptors can form dimers or higher ordered oligomers, but the functional significance of this phenomena remains unclear (Bouvier, 2001; Chabre et al., 2003; Fotiadis et al., 2003; Kühn, 1984; Salahpour et al., 2000) .
Some authors propose a dimer of GPCRs is required for G-protein activation (Baneres and Parello, 2003; Liang et al., 2003) , but monomeric rhodopsins are capable of activating transducin (Jastrzebska et al., 2004; Kühn, 1984) . This raises the question of whether both subunits in a dimeric receptor have to be turned on to activate a G-protein.
Several classes of GPCRs have been defined based on their sequence similarity (Bockaert and Pin, 1999; Fredriksson et al., 2003; Kolakowski, 1994) . Whereas the rhodopsin-like receptors constitute the most abundant class (class A), the secretin-like and metabotropic glutamate-like receptors constitute smaller classes (B and C, respectively) . Class C includes receptors for the two major neurotransmitters, glutamate and GABA, as well as the Ca 2+ -sensing and some taste and pheromone receptors . Most of these class C GPCRs are constitutive dimers, with the two subunits being covalently linked by a disulfide bridge Romano et al., 1996; Tsuji et al., 2000) . This has been firmly demonstrated for the mGlu and Ca 2+ -sensing receptors, and is likely the case for the taste and pheromone receptors, but not for the GABA B receptor . However, the latter is an obligatory heterodimer composed of the GABA B1 and GABA B2 subunits stabilized by an intracellular coiled-coil interaction ). Such receptors therefore constitute an excellent model to examine the specific role of the two subunits in G-protein activation.
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In addition to the heptahelical domain (HD), which is typical for all GPCRs, class C receptors possess a large extracellular domain consisting of a Venus Flytrap domain (VFT). Biochemical and structural studies further demonstrate direct interaction between the two VFTs in these dimeric receptors (Kunishima et al., 2000; Liu et al., 2004; . Structural as well as functional analysis indicate that a important change in the relative orientation of the two VFTs resulting from their closure upon agonist binding is a necessary step for receptor activation (Bessis et al., 2002; Kniazeff et al., 2004b; Kunishima et al., 2000; Tsuchiya et al., 2002) . As such, the dimeric nature of these receptors appears crucial for the intramolecular transduction -i.e. transfer of information from the VFT to the HD. Despite these differences, HDs of class A and class C GPCRs likely function in a similar manner (Binet et al., 2004; Goudet et al., 2004) . Of interest, non-competitive antagonists that bind in the HD have been identified for class C GPCRs (Carroll et al., 2001 ; Knoflach et al., 2001; Pagano et al., 2000) . As observed for class A antagonists, most of these compounds stabilize the inactive state, as demonstrated by their inverse agonist activity both on full-length receptors (Carroll et al., 2001; Pagano et al., 2000) and receptors deleted of their VFT (Goudet et al., 2004) .
In the present study, we examined whether a single or two HDs have to be turned on per mGlu1 receptor dimer for full activity. To that aim we used a system that allows the functional expression of mGlu1 dimeric receptors composed of two well defined subunits, each bearing specific mutations. Our data indicate that binding of a single inverse agonist per dimer does not affect receptor activity. This is in contrast to the decreased G-protein coupling efficacy observed when a mutation is introduced in the i3 loop of a single subunit. These, plus other data are consistent with a model in which a single HD is turned on upon activation of such a dimeric receptor.
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RESULTS
Generation of "heterodimeric" mGlu1 receptors.
In order to analyze the role of each subunit in the activation process of homodimeric mGlu receptors, one need to have access to receptors in which engineered mutations are carried by a single subunit only. To that aim, we used the quality control system of the heterodimeric GABA B receptor. In this receptor dimer, the GB1 subunit does not reach the cell surface alone due to the presence of an ER retention signal (RSRR) in its C-terminal intracellular tail. This signal is masked when associated with the C-terminal tail of GB2 (Couve et al., 1998; Margeta-Mitrovic et al., 2000; Pagano et al., 2001) . Accordingly, two chimeric mGlu1 receptors called R1c1 and R1c2 were created by replacing the mGlu1 C-terminal tail by that of GB1 and GB2 subunits, respectively. As expected, R1c1 does not reach the cell surface alone (Fig. 1) , whereas it does if the ER retention signal RSRR is mutated into ASAR (data not shown). As observed with the GABA B receptor, the C-terminal tail of GB2 in R1c2 did not prevent this receptor from reaching the cell surface alone, but allowed R1c1 to be targeted to the surface (Fig. 1 ).
Heterodimers R1c1:R1c2 reach the cell surface
In order to firmly demonstrate R1c1:R1c2 heterodimers exist at the cell surface, TR-FRET experiments were performed with an anti-HA antibody labeled with the donor fluorophore EuCryptate, and an anti-myc antibody labeled with the acceptor fluorophore Alexa647. As shown in Fig. 2a , a large FRET signal was detected in cells expressing HAR1c1 and myc-R1c2, as well as in cells expressing both HA-GB1 and myc-GB2. Such a signal was not observed after mixing cells expressing HA-R1c1 and cells expressing myc-R1c2, and only a small signal was obtained in cells co-expressing HA-R1c2 and the myc-tagged V2 vasopressin receptor (Fig. 2a) despite a similar expression level of each partner at the cell surface (Fig. 2b,c) . Moreover, the FRET signal was directly proportional to the amount of HA-tagged subunit expressed at the cell surface (Fig. 2e ).
These data do not exclude the possibility that myc-R1c2 allows targeting of preformed HA-R1c1 homodimers to the cell surface. This is unlikely the case since the 6 FRET signal detected between HA epitopes in cells expressing HA-R1c1 and myc-R1c2 remains low. It is indeed similar to that measured in cells expressing HA-GB1 and myc-GB2 ( Fig. 2a and e) and thus, likely results from an over-expression of the receptors . In contrast, a clear signal was detected between HA epitopes in cells expressing HA-R1c2 only, demonstrating that homodimers of HA-mGlu1 can be identified using this method (Fig. 2d) .
The proportion of both populations of dimers (R1c1:R1c2 heterodimers and R1c2 homodimers) at the cell surface was further examined by quantifying the expression level of the subunits using ELISA on intact cells. Anti-HA antibody was used to detect either a single or both subunits. Our data revealed that the amount of R1c1 at the cell surface is more than one third of the total amount of subunits (Fig. 3 ). According to these data, we estimated that 72 ± 3 % (n=6) of the receptors corresponded to the R1c1:R1c2 combination when an equal amount of plasmid encoding each subunit was used for transfection. This proportion can be increased by augmenting the proportion of plasmid encoding R1c1 (data not shown).
Functional expression of R1c1 and R1c2 chimeras
In cells expressing R1c1, no quisqualate response could be measured due to the retention of this subunit in the ER (Fig. 4) . However, the presence of the C-terminal tail of GB1 in R1c1 does not prevent coupling of this receptor to G-protein, as indicated by the normal functioning of the equivalent chimera in which the ER retention signal RSRR is mutated into ASAR (R1c1 ASA , Fig. 4) . Similarly, replacement of the C-terminal tail of mGlu1 by that of GB2 did not prevent activation of PLC (Fig. 4) . However, a clear decrease in the maximal effect of quisqualate was observed with either R1c1 ASA or R1c2 even though care was taken to have a similar level of expression of each at the cell surface, as quantified using ELISA. This suggests that the C-terminal tail of either GB1 or GB2 decreases coupling efficacy of the mGlu1 receptor. Regardless, it is important to note that the C-terminal tails of GB1 and GB2 similarly affect the coupling efficacy of the chimeric receptors.
Co-expression of the R1c1 and R1c2 chimeras results in functional heterodimers
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When both R1c1 and R1c2 were co-expressed in the same cells, a clear activation of PLC by quisqualate was observed (Fig. 4) . In order to firmly demonstrate that the R1c1:R1c2 heterodimer was functional, a point mutation was introduced into the i3 loop of R1c2 (R1Xc2). This mutation (F781P) is known to suppress the ability of mGlu1 receptor to activate PLC and adenylyl cyclase (Francesconi and Duvoisin, 1998) .
Mutation of the equivalent residue in the Ca 2+ -sensing receptor to Ala also suppresses coupling (Chang et al., 2000) . As shown in Fig. 4 In cells expressing R1c1 and R1Xc2, the maximal effect was about one third of that measured in cells expressing R1c1 and R1c2 for a similar expression level of these constructs at the cell surface. The same is true with other similar combinations of subunits as long as the c2 version is mutated in the i3 loop (Fig. 5) . Although the absence of functional R1c2 homodimer may explain part of this decrease, only a 30% decrease would be expected since 30% of the receptors are R1c2 homodimers, as described above.
The larger decrease observed suggests that the R1c1:R1Xc2 heterodimer is not as efficient as the control combination in activating PLC. Accordingly, this suggests that both HDs must be able to activate G-proteins to obtain a full receptor activity.
A single non-competitive antagonist does not inhibit activation of dimeric mGlu receptors
In order to examine whether one or both HDs must reach its active state for dimeric receptor activation of G-proteins, we created a mutant mGlu1 receptor sensitive to the mGlu5 selective non-competitive inverse agonist MPEP, as described by others (Pagano et al., 2000) . This mutant, named R1M, displays an agonist-induced activity similar to that of the control receptor (Fig. 5 ). However, in contrast to the wild-type receptor, R1M was fully antagonized by MPEP (IC 50 of 3.7± 1.3 µM). Of interest, the mGlu1 selective non-competitive inverse agonist BAY 36-7620 is still able to antagonize 8 the mutated R1M receptor. The combination R1Mc1:R1Mc2 was also inhibited by MPEP with a similar IC 50 (3.4 ± 1.4 µM) ( Fig. 7 and 8 ).
Next, we examined the effect of MPEP on receptor combinations in which a single subunit was sensitive to MPEP (R1Mc1:R1c2, and R1c1:R1Mc2). As shown in and can stabilize the occupied HD in its inactive state. These data also suggest there is no cooperativity for the MPEP binding in such dimeric receptors. Importantly, these data suggest that for receptor combinations in which one HD is maintained in its inactive state with MPEP, the associated subunit is able to generate the full response of the receptor.
MPEP enhances agonist activity at R1c1:R1MXc2 combination
The effect of intracellular loop mutations indicated that both HDs in a receptor dimer can potentially activate G-proteins. The above results suggest that stabilizing a single HD in an inactive state with an inverse agonist has no effect on the coupling efficacy of a receptor dimer. Taken together, these data suggest that stabilizing one HD in its inactive state favors coupling by the associated subunit.
To directly test this possibility, we examined the effect of MPEP on a receptor dimer in which one HD is wild-type, and the other possesses the MPEP site and is impaired in its ability to activate G-proteins. If the above proposal is correct, then MPEP binding in one subunit should favor receptor activity mediated exclusively by the second subunit. We therefore co-expressed R1c1 that contains a wild-type HD with R1MXc2 that has both an MPEP site and a mutation in the i3 loop. Note that when these subunits are co-expressed, only the R1c1:R1MXc2 combination is functional, since the other receptor combination reaching the cell surface, R1MXc2 homodimer is not functional. As expected according to the above proposal, MPEP was found to enhance the effect of quisqualate in a dose dependent manner (Fig. 10) . This further suggests that preventing the HD of the R1MXc2 subunit to reach its active state, facilitates G-protein activation by the associated subunit.
Discussion
In the present study we examined whether one or both HDs in a dimeric mGlu1 receptor are turned on during receptor activation. To that aim we applied the quality control system of the GABA B receptor to control the formation of dimeric mGlu1
receptors composed of wild-type or differentially mutated subunits. Then we examined the effect of the non-competitive mGlu5 antagonist MPEP on mGlu1 receptor combinations in which a single subunit is made sensitive to MPEP.
Either HDs in homodimeric mGlu receptors can activate G-proteins
We show that mGlu1 receptor dimers in which one HD is impaired in its ability to activate G-proteins are still able to activate PLC. This is nicely illustrated when the i3 loop of R1c2 is mutated (R1Xc2). Indeed, in cells co-expressing this subunit and the R1c1, the R1Xc2 homodimers that are at the cell surface are not functional, such that the measured response can only be generated by the heterodimer in which a single HD is functional. This illustrates that a single HD able to couple to G-protein is sufficient to get a functional dimeric receptor. This is consistent with the finding that the GB2 HD is crucial for G-protein activation by the heterodimeric GABA B receptor. Indeed, a GABA B receptor bearing a single mutation in the i2 or i3 loop of GB2 HD does not activate Gproteins, whereas the equivalent mutation in GB1 HD has a minor effect Robbins et al., 2001) .
Although receptor dimers with one subunit mutated in the i3 loop is functional, a large decrease in the maximal response is observed, even when care was taken to control cell surface density of receptors. Indeed, this decrease is larger (about 60%) than that expected from the loss of function of R1Xc2 homodimers which represent less than 30% of the total number of dimers at the cell surface. This suggests that the R1c1:R1Xc2 heterodimer is less efficient in activating G-proteins than the control R1c1:R1c2 heterodimer. Accordingly, either HDs can activate a G-protein in mGlu dimers. This is reminiscent of our observation that in a GABA B receptor combination in which both subunits possess a GB2 HD, either HD can activate G-proteins (Havlickova et al., 2002) . This is also consistent with our recent data with the mGlu5 receptor (Kniazeff et al., 11 2004a) . In that case we used an R5c2 construct (mGlu5 with the C-terminal tail of GB2) made non functional by a mutation that prevents agonist activation of the receptor, and a R5c1 construct with a wild-type agonist binding site. As such, only the R5c1:R5c2 heterodimers are functional. In that case, whether the i3 loop mutation is introduced in either one of the subunits, a 2 fold decrease in the maximal response was observed.
Although the interpretation of this may be that each HD is capable of activating a Gprotein independently of the other, another explanation is also possible. Indeed, in an activated homodimeric GPCR, either one or the other (but not both) HD may be turned on at a time.
Blocking one HD in its inactive state with an inverse agonist does not impair receptor coupling
As reported previously, the simultaneous introduction of 3 point mutations (one in TM3, and 2 in TM7) into mGlu1 is sufficient to make it sensitive to the mGlu5 selective inverse agonist MPEP (Pagano et al., 2000) . Such mutations did not impair the sensitivity of the receptor to the mGlu1 selective inverse agonist BAY36-7620. Of interest, if a single subunit within the dimer possesses such a site, no effect of MPEP was observed.
However, the receptor was fully antagonized by BAY36-7620 that can bind in both subunits of the dimer. The absence of effect of MPEP is unlikely due to the inability of MPEP to act in a dimeric receptor possessing a single MPEP site. Indeed, MPEP fully blocks a receptor combination in which one subunit is sensitive to MPEP and the other is impaired in its ability to couple to G-protein by an i3 loop mutation (R1Mc1:R1Xc2 combination). Taken together, these data show that binding of an inverse agonist in one HD within a dimer does not impair G-protein coupling efficacy of the dimer.
Either one HD in a dimeric mGlu1 receptor is activated at a time.
How can one reconcile the two apparently opposite observations that i) impairment of G-protein coupling by i3 mutation decreases G-protein activation, whereas ii) binding of an inverse agonist in one HD does not?
If one accepts that the mutation in i3 loop impairs G-protein activation, but not the ability of the HD to reach an active conformation, then our data can be interpreted by a 12 single HD being turned on per dimer at a time (Fig. 11) . According to this model, upon activation of the receptor, 50% of the receptors are active due to the active conformation of one HD (white HD on the left scheme, Fig. 11a ), and 50% due to the active form of the other HD (black HD on the right scheme). If one HD is impaired in its ability to couple to G-proteins (the white one in Fig. 11b ), then only half of the receptor dimers can couple to G-proteins, and as such the maximal response is decreased two fold. In contrast, if one HD (the black one, Fig. 11b ) is blocked in an inactive state due to the presence of MPEP, then activation of the dimer of VFTs has no other possibility than to activate the other HD (the white one), leading to 100% of receptor dimers with the wild-type HD reaching the active state (compare Fig. 11c and 11a) . Accordingly, MPEP is not expected to inhibit such a receptor dimer, as observed here.
In agreement with this proposal, in a receptor dimer comprised of one HD bearing the i3 loop mutation (indicated in white, Fig. 11d ), and the other possessing an MPEP site (indicated in black, Fig. 11d ), only the white HD can reach an active conformation in the presence of MPEP. Because this HD is not able to activate G-proteins, then MPEP is expected to fully block receptor activity (Fig. 11, compare panels d and b) . This is what we observed with the R1Mc1:R1Xc2 combination.
This proposal also explains why MPEP enhances agonist effect in the R1c1:R1MXc2 combination. Indeed, in such a receptor dimer, both HDs may reach their active state in the absence of MPEP, but only one is capable of activating the G-protein.
By adding MPEP, and thus preventing the R1MXc2 (black HD in Fig. 11e ) from reaching the active state, we would expect to observe a higher proportion of R1c1 subunits (white HD in Fig. 11e ) reach the active state, thereby leading to an increase in the maximal response to agonists (Fig. 11 , compare panels e and b).
Why a receptor dimer for G-protein activation?
Within the last five years, accumulating data indicate that class A rhodopsin-like GPCRs can form dimers, including heterodimers (Angers et al., 2002; Bouvier, 2001; Javitch, 2004; Milligan, 2004; Terrillon and Bouvier, 2004) . In some cases, functional interactions between the associated receptors have been observed. For example, activation of a single receptor type has been shown to induce or prevent the desensitization of the associated receptor (Jordan et al., 2001; Lavoie et al., 2002) . There are also some examples where agonist binding in one subunit decreases the signaling of the other (Jordan et al., 2003) , whereas antagonist of one subunit increases agonist affinity or signaling of the associated subunit (Gomes et al., 2004) . Although these observations may well be explained by our proposal that a single HD is activated in a receptor dimer, positive synergistic effect resulting from the activation of both receptor subunits have also been observed (Jordan and Devi, 1999) . However, such effects can result from a cross-talk between the signaling pathways activated by each individual receptor without a prerequisite for heterodimer formation. In addition, the relative proportion of heterodimers versus monomers and homodimers is generally not known, thus making it difficult to draw a clear conclusion as to the functioning of such heterodimers.
Other observations suggest that our proposal that a single HD reaches the active state in a dimeric mGlu receptor may well be relevant to other GPCRs. Indeed, data reported almost 20 years ago (Kühn, 1984) , as well as recently (Jastrzebska et al., 2004) , demonstrated that monomeric rhodopsin can activate transducin, suggesting that in a receptor dimer there is no need for both subunits to be turned on to activate G-proteins.
Moreover, it is generally accepted that a single photon can be detected by the retina, such that a single activated rhodopsin can signal. If rhodopsin exists in a dimeric form in disk membranes, as revealed recently Fotiadis et al., 2004; Liang et al., 2003) , then a single photon will activate a single subunit only, leaving the associated subunit covalently linked with the inverse agonist cis-retinal. Accordingly, a rhodopsin dimer with a single subunit in an active state, and the other stabilized in its inactive state by an inverse agonist is expected to activate transducin. Also of interest, in GPCRs known to function exclusively in a heterodimeric form, such as the GABA B receptor and the sweet and umami taste receptors, only one HD appears to play a pivotal role in Gprotein activation Galvez et al., 2001; Havlickova et al., 2002; Xu et al., 2004) .
Taken together, these data raise the question of the role of GPCR dimerization in G-protein activation. In the case of the class C GPCRs, structural as well as mutational studies indicate that dimerization in required for intramolecular transduction -i.e.
14 transfer of the signal from the VFTs to the HDs. Indeed, it is proposed that a change in the relative orientation of the two VFTs in the dimer (Kniazeff et al., 2004a; Kunishima et al., 2000; Tsuchiya et al., 2002) leads to a different relative position of the HDs (Tateyama et al., 2004) and allows for their activation. As such, a dimeric structure appears intimately linked to function in class C GPCRs. In the case of class A GPCRs, as shown for rhodopsin, although a monomer can activate G-proteins, recent data suggest that the dimeric form couples more efficiently (Jastrzebska et al., 2004) . This is supported by recent data obtained with the yeast α-factor receptor illustrating that each receptor subunit in this dimeric GPCR can be activated independently, but function in concert to activate G-proteins (Chinault et al., 2004) .
Why is the activated dimer of HDs not symmetric?
The most surprising observation of the present study is that the HD dimer in mGluRs does not function in a symmetrical way. This is particularly surprising when one considers that the dimer of VFTs apparently remains symmetric during the activation process, with full activation being observed only when both VFTs are occupied by an agonist and when both are in a closed state (Kniazeff et al., 2004a) . Although other possibilities exist, the simplest way to explain such a rupture of symmetry in a receptor dimer composed of two identical proteins is that there is an external constraint that prevents both HDs from behaving similarly. Recent data suggest that a single heterotrimeric G-protein interacts with a dimer of GPCRs (Baneres and Parello, 2003) .
Based on the known surface area of the G-protein that contacts the receptor, it has been proposed that both subunits of the receptor dimer contact the G-protein, one HD interacting with the α subunit, and the other with βγ (and the N-terminal alpha helix of the α subunit) Liang et al., 2003) . This proposal is supported by biophysical analysis of the dimer of BLT1 receptors associated with one G-protein heterotrimer (Baneres and Parello, 2003) , as well as by modeling studies Liang et al., 2003) . Accordingly, it is tempting to speculate that the G-protein heterotrimer acts as an external constraint to allow only one of the two HDs to reach the active state. This proposal is in agreement with recent modeling data suggesting that transducin can associate well with a rhodopsin dimer in which only one subunit is in the active state Liang et al., 2003) . Chimeric mGlu1 receptors bearing the C-terminal tail of either GB1 (R1c1) or GB2 (R1c2), starting at position Met873 and Gln761, respectively, were constructed by taking advantage of the restriction site Sph-I (GB1 or GB2 tails inserted after His859) in the mGlu1 sequence.
Materials and methods
Chemicals
In most constructs an HA (hemagglutinin) or a myc tag was introduced in the Nterminal end after the signal peptide. To that aim, the coding sequence of the mature mGlu1 receptor was introduced after the unique Mlu-I restriction site located after the epitope tag of pRKGB1-HA or pRKGB1-myc (Galvez et al., 2001) . The resulting constructs consist of the signal peptide of mGlu5, then either the HA or myc epitope, followed by the mGlu1 coding sequence starting at Ser34. As previously reported for other mGlu (Ango et al., 2000; Havlickova et al., 2003) or GABA B receptors (Galvez et al., 2001; Pagano et al., 2000) , the presence of these tags did not modify the functional expression and pharmacological properties of the mGlu1 receptor.
Cell culture and transfection -HEK293 and COS-7 cells were cultured in Dulbecco's modified Eagle's medium (BRL-Life Technologies, Inc., Cergy Pontoise, France), without sodium pyruvate, supplemented with 10% fetal calf serum, penicillin and streptomycin (100 U/ml final). Electroporation was performed as described elsewhere . For the functional assays we also added the high-affinity glutamate transporter EAAC1 to prevent the influence of glutamate in the medium.
Quantification of cell surface receptors using ELISA -Cell surface expression level of the N-terminal HA-tagged receptors was determined using ELISA as previously described (Balasubramanian et al., 2004; Goudet et al., 2004; Zerangue et al., 1999) .
Transfected cells were fixed with 4% paraformaldehyde, then permeabilized or not using 0.05% Triton X100 (5 min) and incubated for 1 hour with rat monoclonal anti-HA antibody coupled to horseradish peroxydase (clone 3F10 (Roche) at 0.5 µg/ml).
Antibodies were quantified by chemiluminescence using SuperSignal® ELISA femto maximum sensitivity substrate (Pierce) and a Wallac Victor 2 luminescence counter (Molecular Devices).
Time-resolved fluorescence resonance energy transfer (TR-FRET) analysis -These
experiments were conducted as previously described . Briefly, COS- blocks receptor dimer activity when bound to the only active subunit. e) By preventing the black HD from reaching its active state, MPEP increases the probability of the white HD to be turned on, thus leading to a enhancement of the agonist effect. n.e. -no effect. 
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